Created by experts from clinical operations and IT
Secure eConsent
Created by experts from clinical operations and IT
Why should you use it?
eConsent is not just about signatures,it is a whole process. Our eConsent is the secure and easy-to-use companion to support your sites and patients throughout your clinical study lifecycle and beyond.
PharmaTrail’s eConsent is more than just regulatory compliant. With its superior usability and modern look and feel, patients can intuitively use the app without training. Your additional benefit is the awareness that your valuable data is secured by incorruptible blockchain technology. That has the potential to shorten your time to market by creating trust and transparency with regulatory authorities.
Secure eConsent Key Features
Educational Content
Enhance your patient retention by using multimedia content like videos, images, audio, etc. to support better understanding of the study.
Comprehension Confirmation Tools
Ensure a focused consent discussion by enabling the patient to set content flags and integrated feedback loops by the site.
Remote Communication Channels
Enable sites to securely and safely communicate via an integrated video functionality in remote settings!
Business Intelligence
Keep oversight and get analytical insights about your study with our dashboard and reporting tool!
Lifecycle Management
Create initial consents and reconsents on a per site basis and archive your study data securely!
Secure Audit Trail
Reach a new level of trust and transparency with regulatory authorities by using blockchain technology for your audit trail!
Signature Variability
Use eConsent globally despite differing country regulations! Our solution offers simple electronic and wet ink signature on a per case basis. Need an additional signature party? Sure!
Contact us for a product demo and a customized quote: This email address is being protected from spambots. You need JavaScript enabled to view it.
PharmaTrail AG Peter Merian-Strasse 90 CH-4052 Basel This email address is being protected from spambots. You need JavaScript enabled to view it.
